An overview of benefits and risks of chronic melanocortin-1 receptor activation

Area of Science:

• Biochemistry
• Dermatology
• Pharmacology

Background:

• The melanocortin-1 receptor (MC1R) is a G protein-coupled receptor crucial for human skin pigmentation, melanin synthesis, redox balance, and inflammation.
• MC1R dysfunction impacts pigmentation and is linked to conditions like Addison's disease and melasma.
• UV radiation is a primary activator of MC1R, influencing skin's response to sun exposure.

Purpose of the Study:

• To review the role of MC1R in pigmentation and UV response.
• To explore the therapeutic potential of MC1R agonists.
• To assess MC1R activation as a chemoprevention strategy against skin cancer.

Main Methods:

• Review of existing literature on MC1R function and pharmacology.
• Analysis of clinical applications of melanocortin agonists.
• Evaluation of MC1R-targeted photoprotective and chemopreventive strategies.

Main Results:

• MC1R variants affect G protein coupling and cell surface expression, impacting cellular signaling.
• Pharmacologic MC1R agonists are approved for conditions including erythropoietic protoporphyria and obesity.
• MC1R activation, particularly by UV radiation, can enhance photoprotection and DNA repair.

Conclusions:

• MC1R selective agonists show promise for photoprotection and potential melanoma chemoprevention by inducing UV-protective pigmentation and DNA repair.
• While MC1R activation may reduce melanoma risk, it does not prevent it entirely, especially in high-risk individuals.
• Regular skin examinations remain critical for melanoma detection in individuals with risk factors, even with MC1R-targeted interventions.